TP53 LOSS CREATES SUSCEPTIBILITY TO ANTI-POL II THERAPY IN COLORECTAL CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [21] Characterization of TP53 polymorphisms in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina-Elena
    Pitica, Ioana Madalina Aldea
    Mambet, Cristina
    Radu, Elena Lacramioara
    Matei, Lilia
    Dragu, Denisa Laura
    Simion, Laurentiu
    Marincas, Marian Augustin
    Chivu-Economescu, Mihaela
    Cinca, Sabin
    Brasoveanu, Lorelei
    Bleotu, Coralia
    Diaconu, Carmen Cristina
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2018, 23 (06): : 14124 - 14134
  • [22] Should mutant TP53 be targeted for cancer therapy?
    Zilu Wang
    Andreas Strasser
    Gemma L. Kelly
    Cell Death & Differentiation, 2022, 29 : 911 - 920
  • [23] Should mutant TP53 be targeted for cancer therapy?
    Wang, Zilu
    Strasser, Andreas
    Kelly, Gemma L.
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (05): : 911 - 920
  • [24] Loss of TP53 as a prognostic biomarker of poor survival in stage III colorectal cancer patients.
    Nadauld, Lincoln
    Van Hummelen, Paul
    Xia, Li Charlie
    Day, Kenneth
    Lee, Hojoon
    Bell, John
    Grimes, Susan M.
    Kubit, Matt
    Miller, Mickey
    Shin, Giwon
    Wood, Christina
    Greer, Stephanie
    Escobar, Helaman
    Haslem, Derrick S.
    Ji, Hanlee
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Loss of heterozygosity of TP53 is not correlated with clinicopathological variables in sporadic colorectal carcinomas
    González-Aguilera, JJ
    Herrero, MP
    Maillo, C
    Moreno-Azcoita, M
    Fernández-Peralta, AM
    ANTICANCER RESEARCH, 1999, 19 (2A) : 1325 - 1329
  • [26] A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
    Stacey, Simon N.
    Sulem, Patrick
    Jonasdottir, Aslaug
    Masson, Gisli
    Gudmundsson, Julius
    Gudbjartsson, Daniel F.
    Magnusson, Olafur T.
    Gudjonsson, Sigurjon A.
    Sigurgeirsson, Bardur
    Thorisdottir, Kristin
    Ragnarsson, Rafn
    Benediktsdottir, Kristrun R.
    Nexo, Bjorn A.
    Tjonneland, Anne
    Overvad, Kim
    Rudnai, Peter
    Gurzau, Eugene
    Koppova, Kvetoslava
    Hemminki, Kari
    Corredera, Cristina
    Fuentelsaz, Victoria
    Grasa, Pilar
    Navarrete, Sebastian
    Fuertes, Fernando
    Garcia-Prats, Maria D.
    Sanambrosio, Enrique
    Panadero, Angeles
    De Juan, Ana
    Garcia, Almudena
    Rivera, Fernando
    Planelles, Dolores
    Soriano, Virtudes
    Requena, Celia
    Aben, Katja K.
    van Rossum, Michelle M.
    Cremers, Ruben G. H. M.
    van Oort, Inge M.
    van Spronsen, Dick-Johan
    Schalken, Jack A.
    Peters, Wilbert H. M.
    Helfand, Brian T.
    Donovan, Jenny L.
    Hamdy, Freddie C.
    Badescu, Daniel
    Codreanu, Ovidiu
    Jinga, Mariana
    Csiki, Irma E.
    Constantinescu, Vali
    Badea, Paula
    Mates, Ioan N.
    NATURE GENETICS, 2011, 43 (11) : 1098 - U85
  • [27] A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
    Simon N Stacey
    Patrick Sulem
    Aslaug Jonasdottir
    Gisli Masson
    Julius Gudmundsson
    Daniel F Gudbjartsson
    Olafur T Magnusson
    Sigurjon A Gudjonsson
    Bardur Sigurgeirsson
    Kristin Thorisdottir
    Rafn Ragnarsson
    Kristrun R Benediktsdottir
    Bjørn A Nexø
    Anne Tjønneland
    Kim Overvad
    Peter Rudnai
    Eugene Gurzau
    Kvetoslava Koppova
    Kari Hemminki
    Cristina Corredera
    Victoria Fuentelsaz
    Pilar Grasa
    Sebastian Navarrete
    Fernando Fuertes
    Maria D García-Prats
    Enrique Sanambrosio
    Angeles Panadero
    Ana De Juan
    Almudena Garcia
    Fernando Rivera
    Dolores Planelles
    Virtudes Soriano
    Celia Requena
    Katja K Aben
    Michelle M van Rossum
    Ruben G H M Cremers
    Inge M van Oort
    Dick-Johan van Spronsen
    Jack A Schalken
    Wilbert H M Peters
    Brian T Helfand
    Jenny L Donovan
    Freddie C Hamdy
    Daniel Badescu
    Ovidiu Codreanu
    Mariana Jinga
    Irma E Csiki
    Vali Constantinescu
    Paula Badea
    Ioan N Mates
    Nature Genetics, 2011, 43 : 1098 - 1103
  • [28] Coordination of TP53 Abnormalities in Breast Cancer: Data from Analysis of TP53 Polymorphisms, Loss of Heterozygosity, Methylation, and Mutations
    Denisov, Evgeny V.
    Sukhanovskaya, Tatiana V.
    Dultseva, Tatiana S.
    Malinovskaya, Elena A.
    Litviakov, Nicolay V.
    Slonimskaya, Elena M.
    Choinzonov, Evgeny L.
    Cherdyntseva, Nadezhda V.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011, 15 (12) : 901 - 907
  • [29] Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
    Smeby, Jorgen
    Sveen, Anita
    Eilertsen, Ina A.
    Danielsen, Stine A.
    Hoff, Andreas M.
    Eide, Peter W.
    Johannessen, Bjarne
    Hektoen, Merete
    Skotheim, Rolf I.
    Guren, Marianne G.
    Nesbakken, Arild
    Lothe, Ragnhild A.
    ONCOGENESIS, 2019, 8 (6)
  • [30] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina
    Cinca, Sabin
    Simion, Laurentiu
    JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92
12345